Meridian Bioscience Inc (NASDAQ:VIVO)

26.44
Delayed Data
As of Aug 05
 +0.95 / +3.73%
Today’s Change
5.51
Today|||52-Week Range
26.51
+170.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.0B

Company Description

Meridian Bioscience, Inc. engages in the development, manufacture, sale, and distribution of diagnostic test kits, antigens, reagents, and related products. It operates through the following segments: Diagnostics and Life Science. The Diagnostics segment consists testing platforms and technologies such as Isothermal DNA Amplification, Rapid Immunoassay, Enzyme-linked Immunoassay, and Anodic Stripping Voltammetry. The Life Science segment distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

Contact Information

Meridian Bioscience, Inc.
3471 River Hills Drive
Cincinnati Ohio 45244
P:(513) 271-3700
Investor Relations:

Employees

Shareholders

Individual stakeholders5.46%
Mutual fund holders46.65%
Other institutional36.62%

Top Executives

John Patrick KennyPresident, CEO & Executive Director
Bryan T. BaldasareChief Financial Officer, Treasurer & Secretary
Lourdes WeltzienExecutive Vice President-Life Science
Tony Serafini-LamannaExecutive Vice President-Diagnostics
Melissa J. McCareyVice President-Global Human Resources